American Journal of Neuroradiology, Vol 17, Issue 7 1275-1282, Copyright © 1996 by American Society of Neuroradiology
ARTICLES |
Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia
HR Jager, EJ Williams, DG Savage, SA Rule, JV Hajnal, K Sikora, JM Goldman and GM Bydder
Robert Steiner Magnetic Resonance Unit, Hammersmith Hospital, Royal Postgraduate Medical School, London, United Kingdom.
PURPOSE: To determine the frequency and nature of changes to the brain resulting from chemotherapy, radiation therapy, and bone marrow transplantation for chronic myeloid leukemia and to compare the sensitivity of conventional and registered MR scans for detecting these changes. METHODS: In 15 patients, conventional T1-weighted, T2- weighted, and fluid-attenuated inversion recovery MR sequences, as well as T1-weighted radio frequency spoiled 3-D volume MR scans were performed before, 4 to 6 days after, and up to 339 days after transplantation (13 allografts, two autografts). A subvoxel registration program was used to match the volume images precisely so that small changes could be detected after subtraction of scans. Five healthy adult control subjects were also studied on two occasions 1 month apart. RESULTS: Studies performed 4 to 339 days after transplantation showed ventricular enlargement and cortical atrophy in all 13 patients who had allografts. The changes were evident at 4 to 6 days after transplantation and became more obvious during later follow- up examinations. Similar changes were seen in one patient with an autograft but no significant change was seen in the other patient with an autograft or in the five control subjects. Accurately registered volume scans were more sensitive than unregistered conventional scans in detecting early (9/10 versus 0/10), intermediate (12/13 versus 3/12), and late (10/10 versus 4/9) ventricular enlargement on follow-up examinations. The same applied to cortical atrophy (9/10 versus 0/10, 12/13 versus 0/12, and 10/10 versus 0/9). CONCLUSION: The specific cause and clinical significance of these changes are uncertain. Subvoxel registration of serial MR images may reveal changes that are poorly seen or not apparent on conventional scans.
This article has been cited by other articles:
 |
|
 |
|
  M.A. Rocca, T. Mondria, P. Valsasina, M.P. Sormani, Z.H. Flach, P.A. Te Boekhorst, G. Comi, R.Q. Hintzen, and M. Filippi A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1659 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Roccatagliata, M. Rocca, P. Valsasina, L. Bonzano, M. Sormani, R. Saccardi, G. Mancardi, M. Filippi, and for the Italian GITMO-NEURO Intergroup on Autologo The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study Multiple Sclerosis, September 1, 2007; 13(8): 1068 - 1070. [Abstract] [PDF]
|
|
|
|
 |
|
 J. T. Chen, D. L. Collins, H. L. Atkins, M. S. Freedman, A. Galal, D. L. Arnold, and the Canadian MS BMT Study Group Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis Neurology, June 27, 2006; 66(12): 1935 - 1937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Inglese, G L Mancardi, E Pagani, M A Rocca, A Murialdo, R Saccardi, G Comi, and M Filippi Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation J. Neurol. Neurosurg. Psychiatry, April 1, 2004; 75(4): 643 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sostak, C.S. Padovan, T.A. Yousry, G. Ledderose, H.-J. Kolb, and A. Straube Prospective evaluation of neurological complications after allogeneic bone marrow transplantation Neurology, March 11, 2003; 60(5): 842 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vazquez, J. Lucaya, A. Castellote, J. Piqueras, P. Sainz, T. Olive, J. Sanchez-Toledo, and J. J. Ortega Neuroimaging in Pediatric Leukemia and Lymphoma: Differential Diagnosis RadioGraphics, November 1, 2002; 22(6): 1411 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Saiz, E. Carreras, J. Berenguer, J. Yague, C. Martinez, P. Marin, M. Rovira, T. Pujol, T. Arbizu, and F. Graus MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS Neurology, April 24, 2001; 56(8): 1084 - 1089. [Abstract] [Full Text] [PDF]
|
|